Practiceby Lab 10 Get started ›
Crossfire

Should you distrust a study because a company paid for it?

What the experts say

Alan AragonMS · nutrition researcher, educator, and practitioner

Not automatically; check the disclosure, the registration and the agreement

What it rests onConflicting literature on industry funding and favourable outcomes; trial-registration research showing widespread retrospective and missing registration across funders including government and foundation sponsors.

Marion NestlePhD, MPH · Paulette Goddard Professor of Nutrition, Food Studies, and Public Health, Emerita, New York University

Yes, treat it as a red flag, and scientists should decline the money

What it rests onSponsorship-bias literature across food, cigarette, pharmaceutical and medical device research; her own running tally of industry-funded studies with predictable results.

Overview

Nestle is arguing about food-company-funded nutrition research aimed at the general public and about professional ethics for scientists. The paper Aragon signed is arguing about supplement research and is addressed to practitioners. They also differ in what they ask you to do: Nestle's advice has a step (find the funding statement), and so does the paper Aragon signed (find the funding statement, and also the registration).

The disagreement is about what to conclude once you have found it. One thing belongs in plain sight as you weigh this: the paper carrying Aragon's side has eight authors with supplement-industry ties, and that fact is the single strongest piece of evidence for Nestle's side.

Where they agree

Both say check the funding statement. Both say disclosure is mandatory and that undisclosed conflict discredits a finding. The paper Aragon signed states explicitly that if an investigator does not disclose potential conflicts it may cast a negative light on the findings. The live disagreement is whether disclosure plus good design is sufficient, or whether the money itself is the problem.

What would settle it

Nestle would move on evidence that disclosed, registered, agreement-protected industry research produces the same distribution of results as independent research. The position Aragon signed would move on the opposite. Both sides name the same test, which is unusually clean.

Practice does not pick a winner here

You do, and your call is dated, kept, and yours to change. Follow the people you already trust and what they publish turns into a short daily practice.

Get started

Free to sign up and use. We do not ask for a card.